Figure 2.
Effect of 17-AAG treatment on traumatic brain injury-induced motor deficits. The temporal changes in motor recovery were determined at 1, 3, 5 and 7 days following TBI and calculated as ΔNSS. Error bars represent the mean ± standard error (n=5 per group). 17-AAG treatment significantly improved motor function at each time point (*P<0.05, vs. the vehicle group). TBI, traumatic brain injury; 17-AAG, 17-allylamino-demethoxygeldanamycin; NSS, Neurologic Severity Score.